Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effect of RBT-1 on reducing the risk of post-operative complications in subjects undergoing cardiac surgery on cardiopulmonary bypass (CPB). A sub-study will also be conducted to evaluate the pharmacokinetic (PK) profile of a single administration of RBT-1 by means of a popPK approach in subjects scheduled to undergo cardiac surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06021457
Study type Interventional
Source Renibus Therapeutics, Inc.
Contact Jennifer Paleveda
Phone 813-760-3975
Email jpaleveda@renibus.com
Status Recruiting
Phase Phase 3
Start date October 17, 2023
Completion date July 31, 2025